Ictal adiponectin levels in episodic migraineurs: A randomized pilot trial

Headache

Volumn 53, Issue 3, 2013, Pages 474-490

  Peterlin, B Lee ^a   Tietjen, Gretchen E ^b   Gower, Barbara A ^c   Ward, Thomas N ^d   Tepper, Stewart J ^e   White, Linda W ^a   Dash, Paul D ^f   Hammond, Edward R ^g   Haythornthwaite, Jennifer A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adiponectin; biomarker; headache; migraine

Indexed keywords

ADIPONECTIN; DIPHENHYDRAMINE; KETOROLAC; METOCLOPRAMIDE; NAPROXEN PLUS SUMATRIPTAN; OLIGOMER; PLACEBO;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EPISODIC MIGRAINE; FEMALE; HUMAN; ICTAL ADIPONECTIN LEVEL; MOLECULAR WEIGHT; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADIPONECTIN; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; BODY COMPOSITION; CHOLESTEROL; DOUBLE-BLIND METHOD; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN; MIDDLE AGED; MIGRAINE DISORDERS; MOLECULAR WEIGHT; NAPROXEN; NEUROLOGIC EXAMINATION; PAIN MEASUREMENT; PILOT PROJECTS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SUMATRIPTAN; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84875243601     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12071     Document Type: Article

References (18)

1. Peterlin BL, Bigul M, Tepper SJ, Urakaze M, Sheftell FD, Rapoport AM,. Migraine and adiponectin: Is there a connection? Cephalalgia. 2007; 27: 435-446.
2. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA,. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 100-105.
3. Thundyil J, Pavlovski D, Sobey CG, Arumugam TV,. Adiponectin receptor signalling in the brain. Br J Pharmacol. 2012; 165: 313-327.
4. Tilg H, Moschen AR,. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006; 6: 772-783.
5. Neumeier M, Weigert J, Schaffler A, et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol. 2006; 79: 803-808.
6. Perini F, D'Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005; 45: 926-931.
7. Sarchielli P, Floridi A, Mancini ML, et al. NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia. 2006; 26: 1071-1079.
8. Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003; 52: 268-276.
9. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: The HIT-6. Qual Life Res. 2003; 12: 963-974.
10. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
11. Peterlin BL, Alexander G, Tabby D, Reichenberger E,. Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology. 2008; 70: 1905-1911.
12. Simon GE, Von Korff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006; 63: 824-830.
13. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM,. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology. 2003; 60: 1308-1312.
14. Katsuki A, Suematsu M, Gabazza EC, et al. Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care. 2006; 29: 2327-2328.
15. Mangge H, Almer G, Haj-Yahya S, et al. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis. 2009; 203: 277-283.
16. Spranger J, Verma S, Gohring I, et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes. 2006; 55: 141-147.
17. Kos K, Harte AL, da Silva NF, et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab. 2007; 92: 1129-1136.
18. Kadowaki T, Yamauchi T,. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26: 439-451.